Development Of CD96 Antibodies For Cancer Treatment
Funder
National Health and Medical Research Council
Funding Amount
$820,821.00
Summary
There is an unmet medical need to develop new immunotherapies that are safer and potentially allow the treatment of a broader range of cancers. Inhibiting the immune checkpoint CD96 function represents an opportunity that may parallel and indeed complement the activity and impact of other lymphocyte checkpoint inhibitors in human cancer (eg. CTLA-4 and PD1/PD-L1). While developing a new human therapeutic antibody we will also learn more about an important checkpoint in the immune response.
Development Of A Non-invasive Magnetic Resonance Based Cartilage Damage Assessment Technique
Funder
National Health and Medical Research Council
Funding Amount
$556,131.00
Summary
This project will develop automated methods for the extraction of 3D maps of cartilage, bone and other anatomy from high field Magnetic Resonance Images of joints in the body.
Development Of The Listening In Spatialized Noise - Tonal Test (or LiSN-T)
Funder
National Health and Medical Research Council
Funding Amount
$227,136.00
Summary
In this project a novel listening test software will be developed for diagnosing spatial processing disorder in children. These children often have difficulties in understanding teachers in classrooms, which can significantly impact their ability to learn. The developed software will be specifically designed for diagnosing 5-year old children, before they enter primary school, and in contrast to existing tests will be independent of their language background.
MR Hip Intervention And Planning System To Enhance Clinical And Surgical Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$668,069.00
Summary
Degenerative hip disorders and osteoarthritis are a major cause of chronic pain and disability. This project will develop a software tool that allows clinicians to assess, monitor and plan patient treatment using magnetic resonance imaging. It will be the first tool that models joint motion using assessments of bone, cartilage and labral tissue. This will help guide treatment selection and improve outcomes from hip surgeries performed on over 20,000 Australians each year.